Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_assertion type Assertion NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_head.
- NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_assertion wasGeneratedBy ECO_0000203 NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_provenance.
- NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_assertion wasDerivedFrom befree-2016 NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_provenance.
- NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_assertion SIO_000772 17616668 NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_provenance.
- NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_assertion evidence source_evidence_literature NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_provenance.
- NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_assertion description "[One prominent molecular abnormality discovered in these astrocytic brain tumors is alteration of epidermal growth factor (EGF) receptor (EGFR) through gene amplification and/or mutation resulting in excessive signaling from this receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618950.RAzthonN9e-XOS5Bv-y-YLHO_io_6WG6oNtNmpU9OZhy0130_provenance.